COE (80 μg/mL) treatment inhibited hypoxia-induced HCC cell invasion and VM formation, but overexpression of EphA2 partially reversed this inhibitory effect of COE (Figures 4B–E). The gene discussed is EPHA2; the disease is hepatocellular carcinoma.